{"Symbol": "TECH", "AssetType": "Common Stock", "Name": "Bio-Techne Corp", "Description": "Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.", "CIK": "842023", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)", "Address": "614 MCKINLEY PL N E, MINNEAPOLIS, MN, US", "OfficialSite": "https://www.bio-techne.com", "FiscalYearEnd": "June", "LatestQuarter": "2024-12-31", "MarketCapitalization": "7758959000", "EBITDA": "309534000", "PERatio": "50.08", "PEGRatio": "1.0", "BookValue": "13.16", "DividendPerShare": "0.32", "DividendYield": "0.0065", "EPS": "0.98", "RevenuePerShareTTM": "7.57", "ProfitMargin": "0.132", "OperatingMarginTTM": "0.178", "ReturnOnAssetsTTM": "0.0568", "ReturnOnEquityTTM": "0.0783", "RevenueTTM": "1196016000", "GrossProfitTTM": "792003000", "DilutedEPSTTM": "0.98", "QuarterlyEarningsGrowthYOY": "0.294", "QuarterlyRevenueGrowthYOY": "0.09", "AnalystTargetPrice": "79.69", "AnalystRatingStrongBuy": "3", "AnalystRatingBuy": "8", "AnalystRatingHold": "4", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "50.08", "ForwardPE": "21.23", "PriceToSalesRatioTTM": "6.49", "PriceToBookRatio": "3.614", "EVToRevenue": "6.46", "EVToEBITDA": "25.16", "Beta": "1.451", "52WeekHigh": "85.29", "52WeekLow": "46.01", "50DayMovingAverage": "59.45", "200DayMovingAverage": "70.68", "SharesOutstanding": "158088000", "DividendDate": "2025-02-28", "ExDividendDate": "2025-02-14"}